"Iodine Radioisotopes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes.
| Descriptor ID |
D007457
|
| MeSH Number(s) |
D01.268.380.400.500.496 D01.496.448.496 D01.496.749.474
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Iodine Radioisotopes".
Below are MeSH descriptors whose meaning is more specific than "Iodine Radioisotopes".
This graph shows the total number of publications written about "Iodine Radioisotopes" by people in this website by year, and whether "Iodine Radioisotopes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 5 | 7 | 12 |
| 1995 | 1 | 2 | 3 |
| 1996 | 2 | 1 | 3 |
| 1997 | 4 | 0 | 4 |
| 1998 | 0 | 6 | 6 |
| 1999 | 4 | 5 | 9 |
| 2000 | 5 | 7 | 12 |
| 2001 | 2 | 5 | 7 |
| 2002 | 3 | 3 | 6 |
| 2003 | 4 | 8 | 12 |
| 2004 | 1 | 5 | 6 |
| 2005 | 2 | 5 | 7 |
| 2006 | 2 | 6 | 8 |
| 2007 | 2 | 8 | 10 |
| 2008 | 1 | 2 | 3 |
| 2009 | 4 | 4 | 8 |
| 2010 | 3 | 3 | 6 |
| 2011 | 5 | 3 | 8 |
| 2012 | 2 | 6 | 8 |
| 2013 | 0 | 1 | 1 |
| 2014 | 4 | 4 | 8 |
| 2015 | 3 | 7 | 10 |
| 2016 | 2 | 1 | 3 |
| 2017 | 3 | 2 | 5 |
| 2018 | 3 | 2 | 5 |
| 2019 | 2 | 5 | 7 |
| 2020 | 1 | 2 | 3 |
| 2021 | 3 | 6 | 9 |
| 2022 | 2 | 9 | 11 |
| 2023 | 1 | 4 | 5 |
| 2024 | 4 | 6 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Iodine Radioisotopes" by people in Profiles.
-
Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers. Clin Cancer Res. 2024 Sep 03; 30(17):3757-3767.
-
Genomic characterization of cervical lymph node metastases in papillary thyroid carcinoma following the Chornobyl accident. Nat Commun. 2024 Jun 13; 15(1):5053.
-
Re-treatment of locally recurrent uveal melanoma with repeat eye plaque I-125 brachytherapy: A single institution experience. Brachytherapy. 2024 Sep-Oct; 23(5):604-609.
-
Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy. Front Immunol. 2024; 15:1369780.
-
Predicting factors and clinical outcome of biochemical incomplete response in middle eastern differentiated thyroid carcinoma. Endocrine. 2024 Oct; 86(1):268-275.
-
High-Specific-Activity 131 I-MIBG for the Treatment of Advanced Pheochromocytoma and Paraganglioma. Clin Nucl Med. 2024 Jul 01; 49(7):610-620.
-
GRADE-ADOLOPMENT of hyperthyroidism treatment guidelines for a Pakistani context. BMC Endocr Disord. 2024 Mar 21; 24(1):41.
-
Thyroid Cancer: A Review. JAMA. 2024 02 06; 331(5):425-435.
-
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study. Thyroid. 2024 Mar; 34(3):347-359.
-
Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study. Thyroid. 2024 01; 34(1):26-40.